Contents

Current Medicinal Chemistry - Central Nervous System Agents, Volume 4 - Number 3

Preface [Hot Topic: Cannabinoid Receptors (Guest Editor: Maria L. Lopez-Rodriguez)]

, 4(3): i

Maria L Lopez-Rodriguez


DOI: 10.2174/1568015043356986




The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders

, 4(3): 155 - 160

Maria L Lopez-Rodriguez and Silvia Ortega-Gutierrez


DOI: 10.2174/1568015043356959




Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain

, 4(3): 161 - 174

Christopher J. Fowler


DOI: 10.2174/1568015043356968




Involvement of the Endocannabinoid System in Motor Disorders

, 4(3): 175 - 182

J. J. Fernandez-Ruiz, I. Lastres-Becker, A. Cabranes, E. de Lago and J. A. Ramos


DOI: 10.2174/1568015043356922




Involvement of the Endogenous Opioid System in Cannabinoid Responses

, 4(3): 183 - 193

Olga Valverde, Patricia Robledo and Rafael Maldonado


DOI: 10.2174/1568015043356940




The Potential Role of the Endocannabinoid System in the Control of Multiple Scleorsis

, 4(3): 195 - 202

David Baker and Gareth Pryce


DOI: 10.2174/1568015043356977




Serotonin 5-HT7 Receptor Antagonists

, 4(3): 203 - 214

M. L. Lopez-Rodriguez, B. Benhamu, M. J. Morcillo, E. Porras, J. L. Lavandera and L. Pardo


DOI: 10.2174/1568015043356931




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science